PDCD1 and cancer: In head and neck squamous cell carcinoma, miR-375 acted as a modulator to increase the cellular immune response to cancer by inhibiting PD-1/PD-L1 signaling via the Janus kinase 2/signal transducer and activator of transcription 1 pathway [29].